News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Sean Kent

Articles by Sean Kent

104 KATSIS-1: Randomized Phase 3 Trial Evaluating KAT6 Inhibitor PF-07248144 (prifetrastat) Plus Fulvestrant in HR+HER2− Advanced/Metastatic Breast Cancer After Progression on CDK4/6 Inhibitor-Based Therapy

ByKevin Kalinsky, MD, MS,Rachel M. Layman,Antonio Giordano,Toru Mukohara,Yeon Hee Park,Geoffrey J. Lindeman,Giampaolo Bianchini,Alexandre de Nonneville,Véronique Diéras, MD,Sherko Kuemmel,Shusen Wang,Zhiming Shao,Sean Kent,Griffith M. Davis,Meng Li,Mafalda Oliveira

May 19th 2026

Latest Updated Articles

Trending on CancerNetwork

FDA Accepts RP1 BLA Resubmission for Advanced Melanoma

ASCO Breakthrough 2026 Wrap-Up: Precision Oncology, AI, and Biomarkers Define the Future of Cancer Care

Elucidating CAR T-Cell Candidacy for Diffuse Large B-Cell Lymphomas

Epcoritamab/Lenalidomide Significantly Improves PFS in R/R DLBCL

Relapsed/Refractory Multiple Myeloma: Clinical Development and Early Experience With Talquetamab